Skip to content

To evaluate the efficacy of Vatsadani Kwath in the treatment of Vatrakta (Gout)

The Efficacy Of Vatsadani Kwath In Uttan Vatrakta

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051350
Enrollment
30
Registered
2023-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

DEPARTMENT OF KAYACHIKITSA COLLEGE OF AYURVED BHARTI VIDYAPEETH DEEMED TO BE UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients of age between 18-70 years of either sex. • Patients having classical sign and symptoms of Uttan vatarakta . • Patients with serum uric acid level more than 7mg/dl(male) and more than 6mg/dl (female) with associate features like joint pain and inflammation.

Exclusion criteria

Exclusion criteria: • More than 3 years chronicity. • Patients suffering from chronic hepatic disease, renal disease. • Patients of Uttan Vatrakta associated with any of following disorder will be excluded from study such as- Rheumatoid arthritis, Auto immune disease. • Any other inflammatory disorder like tubercular arthritis, septic arthritis.

Design outcomes

Primary

MeasureTime frame
Reduction in Sr. Uric Acid levels.Timepoint: 1 MONTH

Secondary

MeasureTime frame
Reduction in Signs and Symptoms of vatrakta ( reduction in the subjective parameters that in reduction in sandhi shoola, sandhi shotha, sparsh ashayta, raga, tavakvaivarnyta vidaha, stabhdata, chimchimayan. Improvement in VAS scale.Timepoint: 28 Days

Countries

India

Contacts

Public ContactDR DL SHINDE

BHARATI VIDYAPEETH DEEMED TO BE UNIVERSITY, COLLEGE OF AYURVED , PUNE.

dshinde249@gmail.com9890111954

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026